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Methods:
• Standard cell culture procedure was 
done for NSCLC, OS, U937 
(histiocytic leukemia) and T2 
(multiple myeloma) cell lines.
• Reverse transcriptase - polymerase 
chain reaction (RT-PCR) was 
performed to assess endogenous CG 
mRNA.
• Cells were pulsed with a 10:1 ratio 
of PMNs to malignant cell for 4 
hours.
• Cells were stained with appropriate 
antibodies, and we then performed 
flow cytometry to determine CG 
uptake.
• Cytotoxic Assay was performed to 
assess percent killing when cells 
were co-incubated with CG1 
specific cytotoxic lymphocytes 
(CTLs).
Conclusions:
• Both OS and NSCLC show no endogenously express CG
• OS and NSCLC can take up CG when pulsed with irradiated PMNs
• The cytotoxicity assay was inconclusive, likely due to a high concentration of 
CTLs.
• In the future, we will validate CG uptake in multiple OS and NSCLC cells lines 
and hope to demonstrate dose-dependent cytotoxicity of target cells.
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Introduction:
• Cathepsin G (CG) is a serine 
protease found in 
Polymorphonuclear Neutrophils 
(PMNs).
• Research suggests some leukemia 
tumor cells can take up CG and 
present its respective peptide 
(CG1) on their surface.
• We hypothesize that CG can be 
taken up by Non-Small Cell Lung 
Cancer (NSCLC) cells and 
Osteosarcoma (OS) cells and be 
presented on their surface as novel 
immunotherapy targets.
Figure 2: A. CG uptake H1650 Non-Small Cell Lung Cancer cells (pulsed at a ratio of 
10:1). B. CG uptake in SaOS2 Osteosarcoma cells (pulsed at a ratio of 7:1)
Figure 1: RT-PCR show no endogenous 
CG MRN in OS or NSCLC cell lines
Results:
• RT-PCR showed no endogenous mRNA expression of CG in NSCLC/OS cells 
lines (Figure 1).
• Flow cytometry analysis in H1650 (NSCLC) showed CG uptake with a 1.25-
fold increase in the CG-mean fluorescence intensity (CG-MFI) vs. non-
pulsed cells (Figure 2).
• Flow cytometry analysis in Saos2 (OS) showed CG uptake with a two-fold 
increase in the CG-MFI vs. non-pulsed cells (Figure 2).
• Cytotoxicity assay showed non-specific killing of both pulsed and control (T2) 
control cells (Figure 3).
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Figure 3: Cytotoxic Assay A. 
T2 control B. H1650 NSCLC
